GE Healthcare Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by GE Healthcare Technologies Inc. on July 21, 2026, covering events occurring on July 21 and July 23, 2026. The filing addresses preliminary financial results for the second quarter of 2026 and significant changes in executive leadership.
Key Financial Metrics
The filing references a press release (Exhibit 99) containing preliminary unaudited revenue and earnings per share (EPS) results for the second quarter of 2026. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes and Management Commentary
The primary material change reported is the departure of the Chief Financial Officer (CFO). James K. (Jay) Saccaro notified the company on July 21, 2026, of his resignation to pursue a role outside the medical technology industry. His last day of employment is August 14, 2026.
Effective August 14, 2026, George Newcomb, currently the Controller and Chief Accounting Officer, has been named interim Chief Financial Officer. Mr. Newcomb will retain his existing roles while the company commences a search for a permanent successor. There are no changes to Mr. Newcomb's compensation arrangements associated with this interim appointment.
Risks and Contingencies
The filing notes that the financial information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings, except as expressly set forth. This limits the legal liability associated with the preliminary financial data within this specific document.
Key Facts for Investor Verification
- Verify the specific Q2 2026 revenue and EPS figures in the press release dated July 23, 2026 (Exhibit 99), as they are not listed in the 8-K text.
- Confirm the timeline for the CFO transition, with James Saccaro departing on August 14, 2026.
- Monitor the progress of the search for a permanent CFO to replace the interim appointee, George Newcomb.
- Note that the preliminary financial results are unaudited and subject to the standard limitations of forward-looking statements.